Get startedLog in
    Picture of LINCOLN PHARMACEUTICALS logo

    LINCOLN — LINCOLN PHARMACEUTICALS Cashflow Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for LINCOLN PHARMACEUTICALS, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2020
    March 31st
    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IAS
    IAS
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line6728379591,0051,222
    Depreciation
    Non-Cash Items6.72-24.6-58.8-85.6-278
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital1.84-196-220-618-419
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities754693761393632
    Capital Expenditures-76.9-87.5-455-143-396
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-232-555-326-224-177
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-309-642-781-366-573
    Financing Cash Flow Items-19.9-11.9-10.4-13.5-12.7
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-378-57.5-25.6-45-51.8
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash67.7-7.03-45-18.86.95